EUVIMEDEUVIMED entdecken
Crossref

Association of elevated interleukin-33 serum levels with tumorstages in patients with prostate cancer

Nazanin Chatrabnous, Abdollah Jafarzadeh, Abass Ghaderi, Ali Ariafar, Najmeh Aminizadeh, Farzaneh Ghassabi, Maryam Nemati

European Cytokine Network · 2019

DOI: 10.1684/ecn.2019.0438 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Cytokine Network, 2019. Verfasst von Nazanin Chatrabnous und 6 weiteren Autor:innen. Beteiligte Einrichtung: Kerman University of Medical Sciences, Medical School, Department of Immunology, Kerman, Iran. Hauptthemen laut MEDLINE: Genetic Predisposition to Disease, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic Predisposition to DiseasePolymorphism, Single NucleotideAllelesBiomarkers, TumorCase-Control StudiesGene FrequencyHumansInterleukin-33MaleMiddle AgedNeoplasm GradingNeoplasm StagingOdds RatioProstatic NeoplasmsRisk

Stichwörter der Autor:innen

gene polymorphisminterleukin-33prostate cancer

Substanzen

Biomarkers, TumorIL33 protein, humanInterleukin-33

Autor:innen und Institutionen

  • Kerman University of Medical Sciences, Medical School, Department of Immunology, Kerman, Iran.
  • Kerman University of Medical Sciences, Medical School, Department of Immunology, Kerman, Iran, Rafsanjan University of Medical Sciences, Research Institute of Basic Medical Sciences, Molecular Medicine Research Center,…
  • Shiraz University of Medical Sciences, School of Medicine, Shiraz Institute for Cancer Research, Shiraz, Iran, Shiraz University of Medical Sciences, School of Medicine, Department of Immunology, Shiraz, Iran.
  • Shiraz University of Medical Sciences, Urology-Oncology Research Center, Shiraz, Iran.
  • Islamic Azad University Branch of Kerman, School of Medicine, Department of Histology, Kerman, Iran.
  • Shiraz University of Medical Sciences, School of Medicine, Department of Bacteriology and Virology, Shiraz, Iran.

Zitieren

APA

Chatrabnous, N., Jafarzadeh, A., Ghaderi, A., Ariafar, A., Aminizadeh, N., Ghassabi, F., & Nemati, M. (2019). Association of elevated interleukin-33 serum levels with tumorstages in patients with prostate cancer. European Cytokine Network. https://doi.org/10.1684/ecn.2019.0438

Vancouver

Chatrabnous N, Jafarzadeh A, Ghaderi A, Ariafar A, Aminizadeh N, Ghassabi F, et al. Association of elevated interleukin-33 serum levels with tumorstages in patients with prostate cancer. European Cytokine Network. 2019. doi:10.1684/ecn.2019.0438

BibTeX
@article{Chatrabnous2019,
  author = {Chatrabnous, Nazanin and Jafarzadeh, Abdollah and Ghaderi, Abass and Ariafar, Ali and Aminizadeh, Najmeh and Ghassabi, Farzaneh and Nemati, Maryam},
  title = {Association of elevated interleukin-33 serum levels with tumorstages in patients with prostate cancer},
  journal = {European Cytokine Network},
  year = {2019},
  doi = {10.1684/ecn.2019.0438}
}
Kostenlos starten →